105 related articles for article (PubMed ID: 305283)
1. Oral high-dose methotrexate with citrovorum factor rescue in metastastic squamous cell carcinoma of the lung.
Tornyos K; Faust H
Cancer; 1978 Feb; 41(2):400-2. PubMed ID: 305283
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate in the treatment of penile carcinoma.
Sklaroff RB; Yagoda A
Cancer; 1980 Jan; 45(2):214-6. PubMed ID: 6985829
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.
Greco FA; Fer MF; Richardson RL; Hande KR; Van Boxtel CJ; Oldham RK
Cancer Chemother Pharmacol; 1978; 1(4):255-7. PubMed ID: 373922
[TBL] [Abstract][Full Text] [Related]
4. Metastatic carcinoma of the penis: complete remission after high dose methotrexate chemotherapy.
Garnick MB; Skarin AT; Steele GD
J Urol; 1979 Aug; 122(2):265-6. PubMed ID: 313458
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
Djerassi I; Rominger CJ; Kim JS; Turchi J; Suvansri U; Hughes D
Cancer; 1972 Jul; 30(1):22-30. PubMed ID: 4537740
[No Abstract] [Full Text] [Related]
6. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
7. High dose methotrexate with citrovorum factor in adult resistant lymphoma.
Turman S; Coleman M; Silver RT; Pasmantier M
Cancer; 1977 Dec; 40(6):2823-8. PubMed ID: 338137
[TBL] [Abstract][Full Text] [Related]
8. Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancer.
Barlow JJ; Piver MS
Gynecol Oncol; 1979 Apr; 7(2):233-8. PubMed ID: 312234
[No Abstract] [Full Text] [Related]
9. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
[No Abstract] [Full Text] [Related]
10. Methotrexate with leucovorin rescue in the treatment of gynecologic malignancies. Preliminary report.
Corder MP; Hively LF; Stone WH; Flannery EP; Justice GR
Oncology; 1975; 32(5-6):275-82. PubMed ID: 180471
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
Ettinger DS; Stanley KE; Nystrom JS
Cancer Treat Rep; 1980; 64(10-11):1017-21. PubMed ID: 6970075
[TBL] [Abstract][Full Text] [Related]
12. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer.
Chang PM; Teng HW; Chen PM; Chang SY; Chu PY; Tsai TL; Tai SK; Wang YF; Huang JL; Yang MH
J Chin Med Assoc; 2008 Jul; 71(7):336-41. PubMed ID: 18653395
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
[TBL] [Abstract][Full Text] [Related]
17. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
Cadman E; Farber L; Berd D; Bertino J
Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate in combination chemotherapy for small cell lung cancer.
Greco FA; Hande KR; Richardson RL; Oldham RK
Recent Results Cancer Res; 1980; 74():50-5. PubMed ID: 6255518
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy (high-dose methotrexate with citrovorum factor rescue, mechlorethamine, and procarbazine) in non-small cell lung cancer.
Bhasin RR; Nogeirie CP
Cancer Chemother Pharmacol; 1983; 11(2):106-7. PubMed ID: 6605217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
